BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Egalet to Host Conference Call and Webcast to Discuss Third Quarter 2017 Financial Results on November 8, 2017

  Egalet today announced that its third quarter 2017 financial results will be released on Wednesday, November 8, 2017.

  October 25, 2017

   · 

  2 min read
• Genetown

  New Clinical Data From Aura Biosciences to Be Featured in Presentation at the American Academy of Ophthalmology 2017 Annual Meeting

  Aura Biosciences announced today that Carol Shields, M.D., Director will present data from the Phase 1b clinical safety study of AU-011 during a late-breaking session at the American Academy of Ophthalmology (AAO) Annual Meeting in New Orleans, Nov. 11-14.

  October 25, 2017

   · 

  3 min read
• 

  Drug Development

  Janssen’s New Darunavir-Based Single Tablet Regimen SYMTUZA Meets Goals in Phase III Study

  The once-daily single tablet complete regimen demonstrates effective viral suppression in HIV-1 patients.

  October 25, 2017

   · 

  9 min read
• Biotech Bay

  SyncThink Mobilizes Eye-Tracking VR Assessment Using Couchbase for Quicker Access to Brain Health Data

  Couchbas announced that SyncThink, a world leader in neuro-technology, has adopted Couchbase to provide secure, HIPAA-compliant, offline capabilities for its EYE-SYNC solution.

  October 25, 2017

   · 

  5 min read
• Business

  Novoheart Strengthens North American Presence Opening New R&D Location at the World-class Cove Facility, UC Irvine, California

  Novoheart, a global stem cell biotechnology company, is pleased to announce that it has opened a new US location in The Cove at UC Irvine, California.

  October 25, 2017

   · 

  5 min read
• New DePuy Synthes Spine Technologies Help Simplify Minimally Invasive Surgery by Enhancing Efficiency and Reducing Steps

  DePuy Synthes today is launching two solutions for minimally invasive spinal fusion surgery designed to simplify the procedure, particularly as MIS gains traction and shows reduced complications compared to open surgery in treating degenerative disc disease in the back.1,2

  October 25, 2017

   · 

  4 min read
• Genetown

  Updated Clinical Data From Combination of X4P-001-IO and Inlyta (Axitinib) in Patients With Clear Cell Renal Cell Carcinoma Will Be Presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

  X4 Pharmaceuticals today announced that the American Association for Cancer Research (AACR) has published Phase 1 data from an ongoing Phase 1/2 study of X4P-001-IO in combination with Inlyta® (axitinib), Pfizer’s VEGFR kinase inhibitor.

  October 25, 2017

   · 

  3 min read
• GS Medical USA Announces New Product Portfolio of Spinal Solutions

  Today, GSM announced the full launch of the AnyPlus Direct Lateral Interbody Fusion System after three months of an alpha launch period, and the Anterior and Posterior Disc Prep Sets.

  October 25, 2017

   · 

  2 min read
• Business

  Praxair Signs New Long-Term Contract With BASF in the U.S. Gulf Coast

  Praxair, Inc., a leading global industrial gas company, and BASF signed a long-term agreement for Praxair to design, build, own, and operate a new syngas processing plant at BASF’s facility in Geismar, Louisiana.

  October 25, 2017

   · 

  2 min read
• Business

  CRO Industry Veteran John Potthoff Joins SynteractHCR Board of Directors

  SynteractHCR announced the appointment of industry veteran John Potthoff to its Board of Directors, effective immediately.

  October 25, 2017

   · 

  2 min read